Materialise N.V. (MTLS)

Materialise is poised for a return to consistent growth and improving margins, led by Medical strength and stabilization of its Software business. The Manufacturing segment faces ongoing headwinds, but expansion into aerospace and defense could create a modest rebound over the next few years. The combination of a low valuation, consistent growth, and higher margins should lead the stock higher, which will be supported by a share buyback program.

Materialise NV (MTLS) Q4 2025 Earnings Call Transcript

LEUVEN, Belgium--(BUSINESS WIRE)---- $MTLS--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Highlights – Fourth Quarter 2025 Total revenue increased by 6.8% to 70,164 kEUR for the fourth quarter of 2025 from 65,680 kEUR for the corresponding 2024 period, boosted by 16.3% growth in our Mat.

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the fourth quarter ended December 31, 2025 on Thursday, February 19, 2026 at 2:30 a.m. ET/8:30 a.m. CET. Senior management will hold a conference call to discuss the fourth quarter 2025 financial results on Thursday, February 19, 2026 at.

Materialise NV (NASDAQ: MTLS - Get Free Report) shares crossed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $5.64 and traded as low as $5.59. Materialise shares last traded at $5.62, with a volume of 56,831 shares. Wall Street Analyst Weigh In Several equities research analysts

Materialise (NASDAQ: MTLS - Get Free Report) and Verra Mobility (NASDAQ: VRRM - Get Free Report) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk. Analyst Ratings This is a summary of

Materialise (MTLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

MTLS, CALX and AA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Dec. 18, 2025.

JRVR, CALX, MTLS, AMX and NWFL have been added to the Zacks Rank #1 (Strong Buy) List on Dec. 18, 2025.

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced the start of its additional listing of its ordinary shares on Euronext Brussels, to complement the existing Nasdaq listing of its American depositary shares (ADSs) representing ordinary shares. The additional listing and trading of the Materialise shares on Euronext Brussels will.

AGYS, KALU and MTLS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 31, 2025.

LEUVEN, Belgium, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it will host an Extraordinary Shareholders' Meeting on Friday, November 14, 2025, at 17:00 CET.

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its plans to pursue an additional listing of its ordinary shares on Euronext Brussels, to complement the existing Nasdaq listing of its American depositary shares (ADSs) representing ordinary shares, and to launch an ADS buyback program. “At Materialise, we are proud of our heritage and our glo.

Materialise's Manufacturing segment continues to face headwinds, driven by exposure to areas like prototyping, automotive, and Europe. Materialise's Medical segment continues to perform well, and the Software segment appears set to rebound in coming quarters. Despite macro challenges, Materialise remains cash flow positive and has a strong net cash position.

Materialise NV (NASDAQ:MTLS ) Q3 2025 Earnings Call October 28, 2025 8:30 AM EDT Company Participants Brigitte de Vet-Veithen - Chief Executive Officer Koen Berges - Chief Financial Officer Conference Call Participants Harriet Fried - Lippert/Heilshorn & Associates, Inc. Troy Jensen - Cantor Fitzgerald & Co., Research Division Presentation Operator Good day, and welcome to the Q3 2025 Materialise Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.